EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells

Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, David Horne, Ravi Salgia iD, Sharad S Singhal

Cancers · 07.07.2024 · 16 (13) · 2478

DOI: 10.3390/cancers16132478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 07.07.2024. Verfasst von Pankaj Garg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GLA University, Mathura 281406, India. Die Arbeit wurde bisher 361-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, National Cancer Institute of the National Institutes of Health, City of Hope’s Beckman Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of drug resistance in cancer cells presents a formidable challenge in modern oncology, necessitating the exploration of innovative therapeutic strategies. This review investigates the latest advancements in overcoming drug resistance mechanisms employed by cancer cells, focusing on emerging therapeutic modalities. The intricate molecular insights into drug resistance, including genetic mutations, efflux pumps, altered signaling pathways, and microenvironmental influences, are discussed. Furthermore, the promising avenues offered by targeted therapies, combination treatments, immunotherapies, and precision medicine approaches are highlighted. Specifically, the synergistic effects of combining traditional cytotoxic agents with molecularly targeted inhibitors to circumvent resistance pathways are examined. Additionally, the evolving landscape of immunotherapeutic interventions, including immune checkpoint inhibitors and adoptive cell therapies, is explored in terms of bolstering anti-tumor immune responses and overcoming immune evasion mechanisms. Moreover, the significance of biomarker-driven strategies for predicting and monitoring treatment responses is underscored, thereby optimizing therapeutic outcomes. For insights into the future direction of cancer treatment paradigms, the current review focused on prevailing drug resistance challenges and improving patient outcomes, through an integrative analysis of these emerging therapeutic strategies.

Schlagwörter

Stichwörter der Autor:innen

adaptive strategiesbiomarker driven approachesdrug-resistance mechanismsimmune checkpoint inhibitorsprecision medicinetargeted therapiestumor microenvironment

Autor:innen und Institutionen

  • Department of Chemistry, GLA University, Mathura 281406, India.
  • Departments of Medical Oncology & Therapeutics Research, Beckman Research Institute of City of Hope, Comprehensive Cancer Center, National Medical Center, Duarte, CA 91010, USA.
  • Molecular Medicine, Beckman Research Institute of City of Hope, Comprehensive Cancer Center, National Medical Center, Duarte, CA 91010, USA.

ORCID-Profile: Ravi Salgia

Förderung

  • United States Department of Defense
  • National Cancer Institute of the National Institutes of Health
  • City of Hope’s Beckman Research Institute

Zitieren

APA

Garg, P., Malhotra, J., Kulkarni, P., Horne, D., Salgia, R., & Singhal, S. S. (2024). Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells. Cancers, 16(13), 2478. https://doi.org/10.3390/cancers16132478

Vancouver

Garg P, Malhotra J, Kulkarni P, Horne D, Salgia R, Singhal SS. Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells. Cancers. 2024;16(13):2478. doi:10.3390/cancers16132478

BibTeX
@article{Garg2024,
  author = {Garg, Pankaj and Malhotra, Jyoti and Kulkarni, Prakash and Horne, David and Salgia, Ravi and Singhal, Sharad S},
  title = {Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {13},
  pages = {2478},
  doi = {10.3390/cancers16132478}
}
Kostenlos starten →